Global Taking the massive Microsoft acquisition of videogame company Activision Blizzard as his jumping-off point, Shawview Consulting’s Brendan Shaw lays out six key life science industry trends to watch in the coming year and wonders whether 2022 will be pharma’s ‘Call of Duty’ moment. A few weeks ago, 2022 started…
Trends As we move further into 2019, Emmanuel Fombu, MD, MBA: Author and Global Commercial Strategy and Digital Innovation Leader at Johnson and Johnson, reflects on what to expect from the rest of the year and beyond in the pharmaceutical landscape. The battle for market share in the future will likely…
Canada Moving into the position of National Pharma & Life Sciences Leader, PwC’s Rami El-Cheikh announces the firm’s plan to introduce the comprehensive Pharma Advisory Services currently existing in the US into Canada, including enterprise and function-specific service expertise. He further identifies areas of potential growth in healthcare-related industries, putting forward…
Pharma Rafael Gual, general director of CANIFARMA, the chamber that brings together multinational and local drug manufacturers, details how the organization is currently intensifying its efforts to ensure the pharmaceutical industry as a whole is officially recognized as a strategic Mexican industry by both the Ministries of Health and Economy, while…
See our Cookie Privacy Policy Here
